The Oncology Institute, Inc. (TOI)
The Oncology Institute, Inc. (TOI) is a value-based oncology care provider that operates a network of outpatient cancer treatment centers across the United States. The company focuses on delivering affordable, personalized cancer care through clinical research, evidence-based treatment, and comprehensive services. Its mission is to improve access to high-quality cancer care, especially in underserved communities.
TOI’s integrated care model includes diagnostics, chemotherapy, radiation therapy, and supportive care, all offered in community settings. Its growth strategy relies on expanding its geographic footprint, partnering with payers for value-based contracts, and acquiring oncology practices that align with its care model. TOI’s approach helps reduce costs and improve outcomes for patients and insurers alike.
Investors are drawn to TOI’s scalable platform, patient-centric model, and alignment with healthcare cost containment trends. The company’s emphasis on value-based care and population health initiatives positions it well amid shifting healthcare priorities. As more providers move away from fee-for-service models, TOI’s leadership in oncology care delivery could provide long-term upside. Chart
